BIOPHTA
Paris
About BIOPHTA
BIOPHTA has pioneered a new approach to eye care by creating a cutting-edge pharmaceutical platform that enables continuous drug delivery. Their non-invasive topical ocular inserts represent a significant advancement in the treatment of many ophthalmic disorders, providing superior long-term disease management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.1M
- Funding stage: Seed
- Last round: Seed (Jun 2024)
- Website: biophta.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/biophta-20483 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.